Aarti Pharmalabs Share Price
862.25-5.85 (-0.67%)
-1.93% past 1 Year
News
Aarti Pharma reports higher first quarter EBITDA and margin expansion
Equity
AARTIPHARM
Aarti Pharma Q1 revenue rises to Rs 536 crores year on year
Equity
AARTIPHARM
Aarti Pharma reports Q1 standalone net profit rises to Rs 76.10 crores
Equity
AARTIPHARM
Aarti Pharmalabs reports lower Q4 profit, revenue rises year on year
Equity
AARTIPHARM
Aarti Pharmalabs Q4 FY Earnings show weaker EBITDA and margin performance YoY
Equity
AARTIPHARM
Aarti Pharma Q4 EBITDA declines year-on-year with margin compression reported
Equity
AARTIPHARM
Aarti Pharma Q4 profit declines sharply amid extraordinary revenue collapse YoY
Equity
AARTIPHARM
Aarti Pharmalabs reports Profit after tax of 62.03 Crores, in the March 2026 quarter
Equity
AARTIPHARM
Aarti Pharmalabs informs about conference call
Equity
AARTIPHARM
Aarti Pharmalabs informs about analyst meet
Equity
AARTIPHARM
Aarti Pharmalabs informs about substantial acquisition of shares & takeovers
Equity
AARTIPHARM
Aarti Pharmalabs informs about disclosure
Equity
AARTIPHARM
Aarti Pharmalabs Receives One Procedural US FDA Form 483 Observation at Tarapur Unit-IV.
Equity
AARTIPHARM
Aarti Pharmalabs informs about disclosures
Equity
AARTIPHARM
Aarti Pharmalabs Reports Minor Chemical Leak at Tarapur Unit-VI, 22 Workers Hospitalised, No Casualties.
Equity
AARTIPHARM
Aarti Pharmalabs informs about transcript of earnings call
Equity
AARTIPHARM
Aarti Pharmalabs Q3 EBITDA Declines to Rs 102 Crores, Margin Slightly Down YoY.
Equity
AARTIPHARM
Aarti Pharmalabs reports Profit after tax of 43.85 Crores, in the December 2025 quarter
Equity
AARTIPHARM
Aarti Pharmalabs Q3FY26 Earnings: Net Profit Down 35% YoY to Rs 48 Cr, Revenue Falls 20% YoY.
Equity
AARTIPHARM
Aarti Pharmalabs informs about closure of trading window
Equity
AARTIPHARM